Your new experience awaits. Try the new design now and help us make it even better

MINI REVIEW article

Front. Immunol.

Sec. Mucosal Immunity

This article is part of the Research TopicHost-Pathogen Interactions in Mucosal ImmunologyView all 6 articles

The Role of Clostridium butyricum and Its Metabolites in Modulating Gut Mucosal Immunity: Implications for Viral Infections and Inflammatory Diseases

Provisionally accepted
Shaoju  QianShaoju Qian*Siyu  LiSiyu LiKeyan  YeKeyan YeShuao  LuShuao LuXiaoming  ShaXiaoming ShaDanqiong  ZhangDanqiong ZhangZhishan  XUZhishan XUXiangfeng  SongXiangfeng SongRuixue  LiRuixue Li*
  • School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China

The final, formatted version of the article will be published soon.

With global viral emergence and increasing antiviral resistance, there is an urgent need for innovative immunomodulatory strategies. Gut microbiota modulation has gained attention as a promising therapeutic approach. Clostridium butyricum (C. butyricum) plays a pivotal role in shaping microbial composition, preserving intestinal barrier integrity, and enhancing mucosal immunity. Its major metabolites, short-chain fatty acids (SCFAs), further strengthen mucosal defenses and exert antiviral and anti-inflammatory effects. This review proposes a unified “gut-centric hypothesis” that intestinal barrier integrity, microbial homeostasis, and mucosal immune balance collectively determine the host’s resilience to viral invasion and inflammation. The collective findings delineate a mechanistic axis whereby C. butyricum orchestrates antiviral and anti-inflammatory immunity through the induction of type I/III interferons, modulation of inflammasome signaling, and expansion of regulatory immune populations, reinforcing its therapeutic promise. This review provides a new conceptual framework linking probiotic action to antiviral immunity, identifying C. butyricum as a potential next-generation microbial therapeutic for viral and inflammatory diseases.

Keywords: Antiviraleffects, Clostridium butyricum, intestinal barrier, mucosal immunity, Relieve inflammation, short-chain fatty acids

Received: 09 Dec 2025; Accepted: 02 Feb 2026.

Copyright: © 2026 Qian, Li, Ye, Lu, Sha, Zhang, XU, Song and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Shaoju Qian
Ruixue Li

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.